- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Multiple myeloma
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Plitidepsin – July 2019
Plitidepsin: Powder for I.V. infusion 2 mg with 4 mL solvent; Aplidin®
Last updated
15 November 2019